the Acute Myocardial Infarction Study in Northeastern China

Second Hospital of Jilin University1 site in 1 country3,159 target enrollmentSeptember 9, 2019

ConditionsAcute Myocardial Infarction

Overview

Phase: N/A
Intervention: Not specified
Conditions: Acute Myocardial Infarction
Sponsor: Second Hospital of Jilin University
Enrollment: 3159
Locations: 1
Primary Endpoint: all-cause death
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Registry

clinicaltrials.gov

Start Date

September 9, 2019

End Date

September 9, 2022

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Second Hospital of Jilin University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)